How I Treat In Brief

How I Treat In Brief

Condensed versions of the diagnostic and therapeutic advice presented by experts in the field

How I Treat In Brief: Managing Monoclonal Gammopathy of Undetermined Significance

This month, Ronald S. Go, MD, and S. Vincent Rajkumar, MD, discuss the management of patients with monoclonal gammopathy of undetermined significance (MGUS). This material was...

How I Treat In Brief: HCT for HIV-Related Hematologic Malignancies

This month, Joseph C. Alvarnas, MD, John A. Zaia, MD, and Stephen J. Forman, MD, discuss the use of hematopoietic cell transplantation (HCT) to...

How I Treat In Brief: Type 2B von Willebrand Disease

This month, Rebecca Kruse-Jarres, MD, MPH, and Jill M. Johnsen, MD, discuss the diagnosis and treatment of patients with type 2B von Willebrand disease...

How I Treat In Brief: Post-Transplant, Relapsed Classical Hodgkin Lymphoma

This month, Lapo Alinari, MD, PhD, and Kristie A. Blum, MD, discuss treatment options for patients with classical Hodgkin lymphoma (cHL) whose disease has...

How I Treat in Brief: New Agents in Myeloma

This month, Philippe Moreau, MD, discusses the changing landscape of multiple myeloma (MM) therapeutics and options for treatment in frontline and relapsed settings. This material...

How I Treat in Brief: Double-Hit Lymphoma

This month, Jonathan W. Friedberg, MD, MMSc, discusses the diagnosis and treatment of patients with double-hit lymphoma. This material was repurposed from “How I Treat...

How I Treat In Brief: Atypical Chronic Myeloid Leukemia

This month, Jason Gotlib, MD, discusses the diagnosis and treatment of patients with atypical chronic myeloid leukemia. This material was repurposed from “How I Treat...
Advertisement

Current Issue

August 2018, Volume 4, Issue 10

This issue features a look at direct-to-consumer pharmaceutical advertising, advice to graduating hematologists, and more.